Market Overview:
The global nanoparticles market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for nanotechnology-based products in various applications such as hospitals, ambulatory surgery centers, and diagnostic centers. In addition, the growing awareness about the benefits of nanotechnology is also contributing to the growth of this market. Based on type, liposomes are expected to account for the largest share of the global nanoparticles market in 2018. This can be attributed to their ability to encapsulate drugs and other molecules within their lipid bilayer membrane and protect them from degradation during transport through body tissues.
Product Definition:
Nanoparticles are particles of matter that have at least one dimension measuring less than 100 nanometers. Nanoparticles can be made of several different materials, including metals, semiconductors, and plastics. Their small size and unique properties make them useful in a variety of applications, from consumer products to biomedical devices.
Liposomes:
Liposomes are small vesicular structures composed of phospholipids and water. They are naturally occurring organelles that play a significant role in the internal signaling pathway of cells. Liposomes possess membrane-spanning properties which allow them to cross the blood-brain barrier and reach into brain tissue, thereby acting as an intracellular signal transduction mechanism by affecting target cell behavior.
Polymer-Conjugated Drugs:
Polymer-conjugated drugs are synthetic molecules that are made up of monomers connected by polymers. These conjugates can be used as drug delivery systems for various biological targets such as enzymes, cells, and tissues. Polymer-conjugated nanoparticles (PCNPs) market is expected to witness lucrative growth over the forecast period owing to increasing demand in pharmaceuticals and biotechnology industry coupled with rising research activities in the field of nanotechnology.
Application Insights:
The hospital segment dominated the global nanoparticles market in 2017 and is expected to witness a CAGR of XX% over the forecast period owing to an increase in demand for targeted drug delivery systems, nanodiagnostics, and imaging agents that can detect cancer cells or pathogens at early stages. Nanoparticles are widely used in various medical applications such as drug delivery devices, diagnostic reagents, tissue engineering products & solutions, gene therapy products & solutions and others.
Ambulatory surgery centers accounted for a significant share of the overall revenue due to an increase in awareness about minimally invasive procedures among consumers as well as healthcare providers globally. Minimally invasive surgeries involve use of surgical tools with smaller size than conventional ones which allows surgeons to perform complex procedures with less pain & trauma compared to traditional surgeries performed by microscopes or cameras attached onto operating microscopes (OMs).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% during the forecast period. This can be attributed to increasing R&D investments by various companies and rising adoption of nanotechnology-based products in this region. Moreover, growing healthcare awareness levels among people and rapid technological advancements are also contributing toward regional growth.
Growth Factors:
- Increasing demand for nanotechnology-enabled products in various end-use industries
- Rising investments by key players for the development of innovative nanoparticles
- Growing number of research and development activities for the commercialization of novel nanoparticles
- Proliferation of nanotechnology start-ups that are focused on developing novel applications for nanoparticles
- Rising awareness about the benefits of using nanoparticles in various industrial and commercial applications
Scope Of The Report
Report Attributes
Report Details
Report Title
Nanoparticles Market Research Report
By Type
Liposomes, Polymer-Conjugated Drugs, Polymeric Nanoparticles, Dendrimers, Inorganic Nanoparticles, Others
By Application
Hospitals, Ambulatory Surgery Centers, Diagnostic Centers
By Companies
Novartis, Gilead Sciences, Johnson & Johnson, Amgen, Sigma-Tau Pharmaceuticals, Abraxis Biosciences, Nano Interface Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
205
Number of Tables & Figures
144
Customization Available
Yes, the report can be customized as per your need.
Global Nanoparticles Market Report Segments:
The global Nanoparticles market is segmented on the basis of:
Types
Liposomes, Polymer-Conjugated Drugs, Polymeric Nanoparticles, Dendrimers, Inorganic Nanoparticles, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgery Centers, Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Gilead Sciences
- Johnson & Johnson
- Amgen
- Sigma-Tau Pharmaceuticals
- Abraxis Biosciences
- Nano Interface Technology
Highlights of The Nanoparticles Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liposomes
- Polymer-Conjugated Drugs
- Polymeric Nanoparticles
- Dendrimers
- Inorganic Nanoparticles
- Others
- By Application:
- Hospitals
- Ambulatory Surgery Centers
- Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nanoparticles Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nanoparticles are particles that have a diameter of less than 100 nanometers.
Some of the key players operating in the nanoparticles market are Novartis, Gilead Sciences, Johnson & Johnson, Amgen, Sigma-Tau Pharmaceuticals, Abraxis Biosciences, Nano Interface Technology.
The nanoparticles market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nanoparticles Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Nanoparticles Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Nanoparticles Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Nanoparticles Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Nanoparticles Market Size & Forecast, 2020-2028 4.5.1 Nanoparticles Market Size and Y-o-Y Growth 4.5.2 Nanoparticles Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Liposomes
5.2.2 Polymer-Conjugated Drugs
5.2.3 Polymeric Nanoparticles
5.2.4 Dendrimers
5.2.5 Inorganic Nanoparticles
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgery Centers
6.2.3 Diagnostic Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nanoparticles Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nanoparticles Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Liposomes
9.6.2 Polymer-Conjugated Drugs
9.6.3 Polymeric Nanoparticles
9.6.4 Dendrimers
9.6.5 Inorganic Nanoparticles
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgery Centers
9.10.3 Diagnostic Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Liposomes
10.6.2 Polymer-Conjugated Drugs
10.6.3 Polymeric Nanoparticles
10.6.4 Dendrimers
10.6.5 Inorganic Nanoparticles
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgery Centers
10.10.3 Diagnostic Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Liposomes
11.6.2 Polymer-Conjugated Drugs
11.6.3 Polymeric Nanoparticles
11.6.4 Dendrimers
11.6.5 Inorganic Nanoparticles
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgery Centers
11.10.3 Diagnostic Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Liposomes
12.6.2 Polymer-Conjugated Drugs
12.6.3 Polymeric Nanoparticles
12.6.4 Dendrimers
12.6.5 Inorganic Nanoparticles
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgery Centers
12.10.3 Diagnostic Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Liposomes
13.6.2 Polymer-Conjugated Drugs
13.6.3 Polymeric Nanoparticles
13.6.4 Dendrimers
13.6.5 Inorganic Nanoparticles
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgery Centers
13.10.3 Diagnostic Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nanoparticles Market: Competitive Dashboard
14.2 Global Nanoparticles Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Gilead Sciences
14.3.3 Johnson & Johnson
14.3.4 Amgen
14.3.5 Sigma-Tau Pharmaceuticals
14.3.6 Abraxis Biosciences
14.3.7 Nano Interface Technology